Invenomic Capital Management LP

CIK 0001769456 · BOSTON, MA · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Invenomic Capital Management LP reported 116 positions worth $1.67B as of June 30, 2026 (13F filed August 14, 2026). Largest holding: GPN (3.8%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$1.67B
2026 Q2
Positions
116
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
29.2%
Est. Net Flow (Q)
2026 Q2
10 / 116 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1GPNGLOBAL PMTS INCSH$64.0M3.82%881,579
2UHSUNIVERSAL HLTH SVCS INCSH$63.5M3.79%427,264
3WDAYWORKDAY INCSH$58.3M3.48%476,106
4XRAYDENTSPLY SIRONA INCSH$52.1M3.11%4,909,808
5SPSCSPS COMM INCSH$49.7M2.97%869,410
6PVHPVH CORPORATIONSH$42.7M2.55%575,346
7BDXBECTON DICKINSON & COSH$41.3M2.47%273,182
8FISFIDELITY NATL INFORMATION SVSH$41.2M2.46%1,060,601
9CHTRCHARTER COMMUNICATIONS INCSH$40.2M2.40%282,416
10EGOELDORADO GOLD CORP NEWSH$36.0M2.15%1,157,819

The free plan shows the top 10 positions. The remaining 106 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Invenomic Capital Management LP hold as of Q2 2026?

Invenomic Capital Management LP reported 116 positions worth $1.67B in its Q2 2026 13F filing. Largest positions: GPN (3.8%), UHS (3.8%), WDAY (3.5%), XRAY (3.1%) and SPSC (3.0%).

What did Invenomic Capital Management LP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Invenomic Capital Management LP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.